| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/15/2011 | US7888379 Thiazole derivatives and use thereof |
| 02/15/2011 | US7888366 2,4-diaminoquinazolines for spinal muscular atrophy |
| 02/15/2011 | US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 02/15/2011 | US7888354 Phenylpyrazole derivatives |
| 02/15/2011 | US7888353 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators |
| 02/15/2011 | US7888352 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticarcinogenic agent; |
| 02/15/2011 | US7888344 Fused thiazole derivatives as kinase inhibitors |
| 02/15/2011 | US7888336 Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity |
| 02/15/2011 | CA2592986C Heteroaromatic quinoline compounds |
| 02/15/2011 | CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 02/15/2011 | CA2444895C Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 02/15/2011 | CA2377085C Substituted benzimidazoles |
| 02/10/2011 | WO2011017578A1 Sphingosine-1-phosphate receptor agonists |
| 02/10/2011 | WO2011017350A2 Compounds as lysophosphatidic acid receptor antagonists |
| 02/10/2011 | WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 02/10/2011 | WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016530A1 Novel 4-heterocyclic ring-substituted pyrimidine derivative, and pest organism control agent for agricultural and horticultural applications comprising same |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011016470A1 Sulfone derivative |
| 02/10/2011 | WO2011016469A1 Amide derivative |
| 02/10/2011 | WO2011016234A1 Picolinamide derivatives as ttx-s blockers |
| 02/10/2011 | WO2011015728A1 Novel dihydroindolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/10/2011 | WO2011015658A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015037A1 Antiviral compounds and methods of making and using there of cross reference to related applications |
| 02/10/2011 | WO2009088989A9 Process for the preparation of capecitabine |
| 02/10/2011 | US20110034700 Chiral bisoxazoline catalysts |
| 02/10/2011 | US20110034689 N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as ErbB Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases |
| 02/10/2011 | US20110034517 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 02/10/2011 | US20110034507 Farnesoid x receptor agonists |
| 02/10/2011 | US20110034483 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/10/2011 | US20110034466 Novel five-membered ring compound |
| 02/10/2011 | US20110034465 Processes for the preparation of rivaroxaban and intermediates thereof |
| 02/10/2011 | US20110034464 Iminopyridine derivatives and use thereof |
| 02/10/2011 | US20110034463 Type iii secretion inhibitors, analogs and uses thereof |
| 02/10/2011 | US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034460 Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them |
| 02/10/2011 | US20110034459 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors |
| 02/10/2011 | US20110034455 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 02/10/2011 | US20110034454 Morpholino pyrimidine derivatives and their use in therapy |
| 02/10/2011 | US20110034453 Aminoacyl Prodrug Derivatives and Medicaments for the Treatment of Thromboembolitic Disorders |
| 02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/10/2011 | US20110034444 Selected cgrp antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 02/10/2011 | US20110034440 Homocysteine synthase inhibitor |
| 02/10/2011 | US20110034439 Acylthiourea compound or salt thereof, and use thereof |
| 02/10/2011 | US20110034435 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers |
| 02/10/2011 | US20110034434 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 02/10/2011 | US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/10/2011 | US20110034417 Substituted piperidine compounds and methods of their use |
| 02/10/2011 | US20110033544 Intranasal pharmaceutical compositions with improved pharmacokinetcs |
| 02/10/2011 | US20110033417 2,3-substituted indole derivatives for treating viral infections |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | CA2770405A1 Sulfone derivative |
| 02/10/2011 | CA2770404A1 Amide derivative |
| 02/10/2011 | CA2770195A1 Aminopyrazole derivative |
| 02/10/2011 | CA2770194A1 Sphingosine-1-phosphate receptor agonists |
| 02/10/2011 | CA2770140A1 Antiviral compounds and methods of making and using thereof cross reference to related applications |
| 02/10/2011 | CA2768638A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/09/2011 | EP2281824A1 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 02/09/2011 | EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives |
| 02/09/2011 | EP2281822A1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 02/09/2011 | EP2281815A1 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2280964A1 Chlorothiophene-isoxazoles as inhibitors of coagulation factors xa and thrombin |
| 02/09/2011 | EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors. |
| 02/09/2011 | EP2280705A1 Novel compounds |
| 02/09/2011 | EP1924579B1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 02/09/2011 | EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1685100B1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 02/09/2011 | EP1597252B1 Pyridine derivatives as fungicidal compounds |
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | CN1984901B Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. |
| 02/09/2011 | CN101970431A Substituted piperidines as therapeutic compounds |
| 02/09/2011 | CN101970430A Novel pyrimidine derivatives |
| 02/09/2011 | CN101970426A Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer |
| 02/09/2011 | CN101970420A Oxadiazole derivatives |
| 02/09/2011 | CN101970419A Substituted triazinylmethyl sulfonamides |
| 02/09/2011 | CN101970417A Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101970403A Pesticidal condensed - ring aryl compounds |
| 02/09/2011 | CN101969945A Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967139A Fluoro methoxylpyrazole-containing o-formylaminobenzamide compound, synthesis method and application thereof |
| 02/08/2011 | US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators |
| 02/08/2011 | US7884107 Substituted piperidines that increase P53 activity and the uses thereof |
| 02/08/2011 | US7884102 Substituted piperidine compounds and methods of their use |
| 02/08/2011 | US7884101 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| 02/08/2011 | US7884098 Anthranilamide inhibitors of aurora kinase |
| 02/08/2011 | US7884097 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 02/08/2011 | CA2622694C Substituted cycloalkene derivative |
| 02/08/2011 | CA2605899C Triazole derivatives as vasopressin antagonists |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2478068C Dihydropyrazole compounds useful for treating or preventing cancer |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/03/2011 | WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION |
| 02/03/2011 | WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |